A Japanese research team has demonstrated that the use of antisense oligonucleotides (ASOs) with modified bases and sugars can enhance the effectiveness of targeting diseases in the central nervous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback